Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Bernardo A. Leone"'
Autor:
José P Leone, Rachel A Freedman, Julieta Leone, Sara M Tolaney, Carlos T Vallejo, Bernardo A Leone, Eric P Winer, Nancy U Lin, Michael J Hassett
Publikováno v:
JNCI: Journal of the National Cancer Institute. 115:421-428
Background Breast cancer mortality in women has declined statistically significantly over the past several years. In men, it is unclear whether survival has changed over time. We evaluated changes in breast cancer–specific survival (BCSS) and overa
Autor:
Jose P Leone, Noah Graham, Julieta Leone, Sara M Tolaney, Bernardo A Leone, Rachel A Freedman, Michael J Hassett, Carlos T Vallejo, Eric P Winer, Nancy U Lin, Nabihah Tayob
Publikováno v:
Cancer Research. 82:P2-10
Background: Triple-negative breast cancer (TNBC) is associated with high risk of distant recurrence and death. At present, our ability to estimate risk of death from causes other than breast cancer is limited. Particularly among elderly patients (pts
Autor:
José P, Leone, Rachel A, Freedman, Julieta, Leone, Sara M, Tolaney, Carlos T, Vallejo, Bernardo A, Leone, Eric P, Winer, Nancy U, Lin, Michael J, Hassett
Publikováno v:
Journal of the National Cancer Institute.
Breast cancer mortality in women has declined significantly over the past several years. In men, it is unclear whether survival has changed over time. We evaluated changes in breast cancer-specific survival (BCSS) and overall survival (OS) in male br
Autor:
José Pablo Leone, Michael J. Hassett, Julieta Leone, Sara M. Tolaney, Carlos T. Vallejo, Bernardo A. Leone, Eric P. Winer, Nancy U. Lin
Publikováno v:
CancerREFERENCES. 128(21)
Neoadjuvant chemotherapy (NAC) is standard for many females with breast cancer (FBC). The efficacy of NAC in male breast cancer (MaBC) is unclear. The aim of this study was to compare proportions of pathologic complete response (pCR) between MaBC and
Autor:
Bernardo Amadeo Leone, Nan Lin, Sara M. Tolaney, Carlos Teodoro Vallejo, Eric P. Winer, Julieta Leone, Jose Pablo Leone, Rachel A. Freedman
Publikováno v:
Breast Cancer Research and Treatment. 188:695-702
Male breast cancer is an uncommon disease, and population-based information regarding prognostic factors is limited. Most cases are hormone receptor (HR) positive; however, the association of tumor subtype with overall survival (OS) and breast cancer
Autor:
Carlos Teodoro Vallejo, Sara M. Tolaney, Nan Lin, Bernardo Amadeo Leone, Eric P. Winer, Julieta Leone, Nabihah Tayob, Jose Pablo Leone, Michael J. Hassett, Rachel A. Freedman
Publikováno v:
Breast Cancer Research and Treatment. 187:843-852
We aimed to report the 20-year risk of breast cancer-specific mortality (BCSM), report the risk of BCSM conditional on having survived 5 years, and identify factors associated with late deaths in stage III breast cancer. Using Surveillance, Epidemiol
Autor:
Nan Lin, Sara M. Tolaney, Bernardo Amadeo Leone, Carlos Teodoro Vallejo, Julieta Leone, Rachel A. Freedman, Jose Pablo Leone, Michael J. Hassett, Eric P. Winer, Nabihah Tayob
Publikováno v:
Cancer Research. 81:PS6-13
Background: The risk of breast cancer death persists for at least 20 years from diagnosis. Most reports describing this risk have been based on selected patients (pts) enrolled into clinical trials. These studies report absolute risks at fixed timepo
Autor:
José P. Leone, Noah Graham, Sara M. Tolaney, Bernardo A. Leone, Rachel A. Freedman, Michael J. Hassett, Julieta Leone, Carlos T. Vallejo, Eric P. Winer, Nancy U. Lin, Nabihah Tayob
Publikováno v:
European journal of cancer (Oxford, England : 1990). 173
The risk of breast cancer-specific mortality (BCSM) persists for at least 20 years from diagnosis. Estimating the risk of BCSM over this extended period along with competing risks of death would aid clinical decision-making. We aimed to develop an in
Autor:
Carlos Teodoro Vallejo, Nu Lin, Rachel A. Freedman, Julieta Leone, EP Winer, Jose Pablo Leone, Sara M. Tolaney, AO Zwenger, Bernardo Amadeo Leone
Publikováno v:
Cancer Research. 79:P6-19
Background: Male breast cancer (MaBC) is an uncommon disease, and population-based information regarding prognostic factors is limited. Most MaBC are hormone receptor (HR) positive, however, the association of tumor subtypes with overall survival (OS
Autor:
Sara M. Tolaney, Eric P. Winer, Jose Pablo Leone, Nabihah Tayob, Julieta Leone, Carlos Teodoro Vallejo, Michael J. Hassett, Nan Lin, Noah Graham, Bernardo Amadeo Leone, Rachel A. Freedman
Publikováno v:
Breast Cancer Research and Treatment
Purpose Most reports describing the risk of late relapse in breast cancer (BC) have been based on selected patients enrolled into clinical trials. We examined population-based long-term risks of BC-specific mortality (BCSM), the risks of BCSM conditi